Squarepoint’s Insmed INSM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $6.43M | Sell |
39,316
-27,086
| -41% | -$4.16M | 0.01% | 1328 |
|
|
2025
Q4 | $11.6M | Buy |
+66,402
| New | +$12.1M | 0.01% | 1014 |
|
|
2025
Q3 | – | Sell |
-210,647
| Closed | -$25.8M | – | 4652 |
|
|
2025
Q2 | $21.2M | Buy |
+210,647
| New | +$16.1M | 0.02% | 738 |
|
|
2024
Q4 | – | Sell |
-485,618
| Closed | -$35M | – | 5254 |
|
|
2024
Q3 | $35.5M | Buy |
485,618
+435,071
| +861% | +$32.1M | 0.06% | 360 |
|
|
2024
Q2 | $3.39M | Buy |
+50,547
| New | +$1.96M | 0.01% | 1655 |
|
|
2024
Q1 | – | Sell |
-78,325
| Closed | -$2.43M | – | 4279 |
|
|
2023
Q4 | $2.43M | Sell |
78,325
-3,922
| -5% | -$102K | ﹤0.01% | 1872 |
|
|
2023
Q3 | $2.08M | Buy |
+82,247
| New | +$1.88M | 0.01% | 1792 |
|
|
2023
Q2 | – | Sell |
-47,253
| Closed | -$806K | – | 3775 |
|
|
2023
Q1 | $806K | Buy |
47,253
+11,743
| +33% | +$228K | ﹤0.01% | 2028 |
|
|
2022
Q4 | $709K | Sell |
35,510
-63,241
| -64% | -$1.22M | ﹤0.01% | 2065 |
|
|
2022
Q3 | $2.13M | Buy |
+98,751
| New | +$2.37M | 0.01% | 1284 |
|
|
2022
Q2 | – | Sell |
-10,583
| Closed | -$249K | – | 3106 |
|
|
2022
Q1 | $249K | Buy |
+10,583
| New | +$246K | ﹤0.01% | 2378 |
|
|
2021
Q4 | – | Sell |
-62,555
| Closed | -$1.72M | – | 3327 |
|
|
2021
Q3 | $1.72M | Buy |
62,555
+49,382
| +375% | +$1.3M | ﹤0.01% | 1277 |
|
|
2021
Q2 | $375K | Buy |
+13,173
| New | +$391K | ﹤0.01% | 2358 |
|
|
2020
Q4 | – | Sell |
-47,840
| Closed | -$1.54M | – | 3083 |
|
|
2020
Q3 | $1.54M | Sell |
47,840
-34,528
| -42% | -$992K | 0.02% | 777 |
|
|
2020
Q2 | $2.27M | Buy |
82,368
+9,068
| +12% | +$215K | 0.04% | 588 |
|
|
2020
Q1 | $1.18M | Buy |
73,300
+45,656
| +165% | +$1.08M | 0.03% | 663 |
|
|
2019
Q4 | $660K | Sell |
27,644
-110,484
| -80% | -$2.25M | ﹤0.01% | 1596 |
|
|
2019
Q3 | $2.44M | Buy |
138,128
+103,628
| +300% | +$2M | 0.02% | 768 |
|
|
2019
Q2 | $883K | Buy |
34,500
+11,046
| +47% | +$308K | 0.01% | 1330 |
|
|
2019
Q1 | $682K | Buy |
23,454
+11,317
| +93% | +$293K | 0.01% | 1318 |
|
|
2018
Q4 | $159K | Sell |
12,137
-24,363
| -67% | -$389K | ﹤0.01% | 1746 |
|
|
2018
Q3 | $738K | Buy |
36,500
+19,344
| +113% | +$437K | 0.01% | 1130 |
|
|
2018
Q2 | $406K | Buy |
+17,156
| New | +$442K | 0.01% | 1262 |
|
|
2017
Q4 | – | Sell |
-23,534
| Closed | -$734K | – | 2203 |
|
|
2017
Q3 | $734K | Buy |
23,534
+1,191
| +5% | +$22.7K | 0.01% | 835 |
|
|
2017
Q2 | $383K | Buy |
+22,343
| New | +$382K | 0.01% | 1048 |
|
|
2016
Q1 | – | Sell |
-11,400
| Closed | -$207K | – | 1301 |
|
|
2015
Q4 | $207K | Buy |
+11,400
| New | +$201K | 0.02% | 977 |
|
Other funds holding INSM
DGM
VPM
VCM
BBA
Squarepoint's INSM Position: Q1 2026 in Review
Squarepoint reduced its Insmed (INSM) stake by 41% in Q1 2026, selling an estimated $4.16M and leaving 39,316 shares worth $6.43M. The position accounts for 0.01% of the portfolio, ranked #1328.
Squarepoint first reported a position in INSM in Q4 2015 and has held it in 26 quarters since. The position peaked at $35.5M in Q3 2024. 669 funds tracked by Wall St. Rank hold INSM as of Q1 2026.
- Squarepoint held 39,316 shares of Insmed worth $6.43M as of Q1 2026.
- Squarepoint sold 27,086 Insmed shares in Q1 2026, an estimated $4.16M.
- Insmed made up 0.01% of Squarepoint's portfolio in Q1 2026, its #1328 holding.
- Squarepoint first reported a position in Insmed in Q4 2015 and has held it in 26 quarters since.
- Squarepoint's Insmed position peaked at $35.5M in Q3 2024.
- 669 funds tracked by Wall St. Rank held Insmed as of Q1 2026.
Based on Squarepoint's 13F filing for Q1 2026, filed 15 May 2026.